CAIAC alliance launched to combat COVID-19 with data

By William Smith
An alliance has been launched with the aim of providing an AI-supported decision-making platform to the world’s policy leaders in the face of COVID-19...

An alliance has been launched with the aim of providing an AI-supported decision-making platform to the world’s policy leaders in the face of COVID-19.

The alliance, known as the Collective and Augmented Intelligence Against COVID-19 (CAIAC), has been formed by the Future Society and Stanford Institute for Human-Centered Artificial Intelligence (HAI), with the support of UNESCO and the Patrick J. McGovern Foundation.

CAIAC is to establish an advisory group, inviting experts from UNESCO, UN Global Pulse and other UN entities, to structure the ever expanding data on global health, both social and economic, to better inform policy makers, as well as healthcare leaders and the scientific community.

On the alliance’s website, Cyrus Hodes, Co-founder & Chair of the AI Initiative at The Future Society, said: “The pandemic has highlighted how vulnerable we are as a civilization. It has also accelerated innovation and global cooperation with the blossoming of thousands of bottom-up initiatives to find solutions. Creating a coherent, truly holistic, knowledge platform for policy makers to navigate the flow of information has become a necessity. Fortunately, modern technologies such as AI can be used to harness vast amounts of disparate data and produce meaningful insights. CAIAC will build this ground-breaking decision-making tool for global leaders to help solve the pandemic and accelerate the economic and social recovery.” 

With the world having been somewhat blindsided by the emergence of COVID-19, in a press release the alliance pointed out the fact that data is being created by research institutions, think-tanks, and NGOs with no trusted filter for their analyses and models. Hence, the organisation is intending to build a dynamic platform in collaboration with private sector partners such as C3.ai, stability.ai, Element AI, Axis, GLG, and Planet to build artificial intelligence into the platform.

The minimum viable product will be focused on three use cases: tracking and tracing contagion chain, identifying inaccurate COVID-19 information, and finding the areas most affected by recurrences of the pandemic.

Share

Featured Articles

The Merck Group: Pharma's History & Innovation in India

Welcome back to part two of our exploration of The Merck Group's history and investment in China and India, with this part focusing on innovation in India

How CVS Health is Rising to the Omnichannel Challenge

US healthcare company CVS Health is reshaping its supply chain to meet the omnichannel needs of its customers

Kinaxis: Pharma Seeing Euro-wide Supply Chain Challenges

Supply chain specialist Kinaxis says UK pharma still recovering from Brexit and pandemic, and that Europe also seeing medicines value chain problems

Healthcare Digital Transformations Stymied by Data Silos

Digital Healthcare

McKinsey: Brain Health Underfunding 'a Global Concern'

Digital Healthcare

Endometriosis Linked to Heart Attacks & Strokes

Medical Devices & Pharma